Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LevelsRx vs Nucific

LevelsRx
Graded #195

Higher grade

vs+10.099999999999994
Nucific
Graded #418

Lower grade

The verdict

LevelsRx takes it — 66.3/100 to 56.2/100.

LevelsRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLevelsRx +22
67
45
Dose & formulationLevelsRx +22
75
53
Clinical oversightEven
76
76
Labs & monitoringEven
52
52
FulfillmentLevelsRx +2
69
67
Contract termsEven
41
41
LevelsRx · left barNucific · right bar

The numbers

MetricLevelsRxNucific
WeighScore66.3/10056.2/100
GradeCC
Scorecard rank#195#418
Semaglutide$150/mo (starting dose, compounded)Not disclosed
Tirzepatide$240/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
LevelsRx

Graded #195 · C

Strengths

  • Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
  • Weight-loss money-back warranty if targets are not met
  • 24-7 phone and email support with unlimited online provider visits

Where it loses points

  • Compounding pharmacy is not named publicly
  • States served are not published on the site
  • Prices are 'starting at' figures that may rise with dose
Nucific

Graded #418 · C

Strengths

  • Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
  • Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
  • Discloses that featured patients were compensated for their time
  • Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
  • Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue

Where it loses points

  • No price is published anywhere; every option is gated behind a three-minute quiz
  • The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
  • A BBB Accredited A+ claim is displayed without a link to the BBB profile
  • No state list and no named pharmacy, only licensed U.S. pharmacies
  • Before-and-after photographs are used alongside compensated testimonials

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard